Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,349,787 papers from all fields of science
Search
Sign In
Create Free Account
pegaptanib
Known as:
pegaptanib [Chemical/Ingredient]
A 28-mer RNA aptamer covalently linked to two branched 20-kD polyethylene glycol (PEG) chains, with anti-angiogenic activity. Pegaptanib binds and…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
0.09 ML pegaptanib 3.33 MG/ML Prefilled Syringe [Macugen]
Pegaptanib Sodium
Broader (1)
Aptamers, Nucleotide
Narrower (3)
EYE 001
Macugen
NX1838
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Langzeitergebnisse bei neovaskulärer altersabhängiger Makuladegeneration
V. Thalgott
,
Nikolaus Feucht
,
C. Lohmann
,
Mathias Maier
Der Ophthalmologe
2016
Corpus ID: 115921200
ZusammenfassungHintergrundStandardtherapie der neovaskulären altersabhängigen Makuladegeneration (nAMD) ist die intravitreale…
Expand
Review
2015
Review
2015
Finding the Optimal Treatment Plan for Exudative AMD: A review of Current Anti-VEGF Dosing Regimens
Avni V. Patel
,
S. Barb
,
L. Young
International ophthalmology clinics
2015
Corpus ID: 20256635
Age-related macular degeneration (AMD) is the leading cause of severe central visual acuity loss in people over 50 years of age…
Expand
2012
2012
Ciliary body medulloepithelioma in a 10-year-old boy.
David A. Lewis
,
S. Nehls
,
J. Rowe
,
Sherif S Khedr
,
H. Potter
A M A Archives of Ophthalmology
2012
Corpus ID: 40351049
gen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med. 2008;14(7):731-737. 22. Klettner A, Roider J…
Expand
Review
2011
Review
2011
Antiangiogenic drugs and advanced proliferative diabetic retinopathy
Efferson
,
ugusto
,
+5 authors
Orge
2011
Corpus ID: 5747690
Advanced diabetic retinopathy with vitreous hemorrhage or tractional retinal detachment (TDR) is an important cause of severe…
Expand
2011
2011
Estudio prospectivo de eficacia y seguridad de pegaptanib sodio en el tratamiento primario del edema macular secundario a trombosis venosa de la retina
M. Vilaró
,
Francisca Bassaganyas Vilarrasa
2011
Corpus ID: 57014300
Objectiu:Avaluar l'eficacia i seguretat de pegaptanib de sodi en el tractament de l'edema macular secundari a obstruccio venosa…
Expand
2011
2011
Antiangiogénicos na Degenerescência Macular Relacionada com a Idade: A Medicina Baseada na Evidência e a Utilização Off-label
J. D. de Abreu
,
Rufino Silva
,
+4 authors
Joaquim Murta
2011
Corpus ID: 72983988
A degenerescência macular relacionada com a idade era, até há pouco tempo nos países desenvolvidos, a principal causa de cegueira…
Expand
2010
2010
Aktualne sposoby leczenia cukrzycowej choroby oczu
J. Pieczyński
,
E. Bandurska-Stankiewicz
,
Dorota Wiatr-Bykowska
,
J. Rutkowska
2010
Corpus ID: 108180104
Cukrzyca wywo³uje wiele powik³an, rownie? ze strony narz±du wzroku. Je?eli nie jest prawid³owo leczona, przez stopniow± utrate…
Expand
2009
2009
Apt screening with microfluidics
M. J. Haas
2009
Corpus ID: 71604093
California researchers have developed a magnetic microfluidic-based platform for isolating high-affinity DNA aptamers in a single…
Expand
Review
2009
Review
2009
Topische antiangiogene Therapie an der Hornhaut : Sicherheit und Effektivität (Leitthema)
B. Regenfuss
,
F. Bock
,
+4 authors
C. Cursiefen
2009
Corpus ID: 78234462
BackgroundThe efficacy and safety of novel topical inhibitors of corneal neovascularisation will be discussed.MethodsA literature…
Expand
2008
2008
Eyelid primary diffuse large B-cell lymphoma.
V. Huerva
,
L. M. Canto
Canadian Journal of Ophthalmology-journal…
2008
Corpus ID: 41187592